Register Login

BIO-TECHNE CORP (TECH)

Director Kelderman Kim 🟢 acquired 455.7K shares (16 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($31.9M) Transaction Date: Aug 17, 2026 | Filing ID: 000133

Full text
Register to leave comments
  • News bot Aug. 19, 2026, 8:49 p.m.

    🔍 Kelderman Kim (Director)

    Company: BIO-TECHNE Corp (TECH)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 17
    • Derivative instruments: 16
    • Holdings reported: 15
    • Total shares acquired: 151,172
    • Total shares held: 689,600

    Detailed Transactions and Holdings:

    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-17 | Code: H | shares_owned_after: 82,762.00
    • Acquired 57,590 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,590.00 | transaction_form_type: 4 | Footnotes: F7, F12, F12
    • Acquired 93,582 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 93,582.00 | transaction_form_type: 4 | Footnotes: F7, F13, F13
    • Holds 115,724 shares of Stock Option (Right to Buy) at $66.97 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2027-08-05 | shares_owned_after: 115,724.00 | Footnotes: F1
    • Holds 25,944 shares of Stock Option (Right to Buy) at $120.46 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2028-08-06 | shares_owned_after: 25,944.00 | Footnotes: F1
    • Holds 28,940 shares of Stock Options (Right to Buy) at $94.52 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2029-08-15 | shares_owned_after: 28,940.00 | Footnotes: F1
    • Holds 1,492 shares of Stock Options (Right to Buy) at $84.61 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2030-08-15 | shares_owned_after: 1,492.00 | Footnotes: F1
    • Holds 29,391 shares of Stock Options (Right to Buy) at $84.61 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2030-08-15 | shares_owned_after: 29,391.00 | Footnotes: F2
    • Holds 38,252 shares of Stock Options (Right to Buy) at $52.83 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2030-11-01 | shares_owned_after: 38,252.00 | Footnotes: F3
    • Holds 1,621 shares of Stock Options (Right to Buy) at $68.54 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2031-02-01 | shares_owned_after: 1,621.00 | Footnotes: F1
    • Holds 51,890 shares of Stock Options (Right to Buy) at $68.54 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2031-02-01 | shares_owned_after: 51,890.00 | Footnotes: F4
    • Holds 69,061 shares of Stock Options (Right to Buy) at $74.91 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2034-08-15 | shares_owned_after: 69,061.00 | Footnotes: F5
    • Holds 90,441 shares of Stock Options (Right to Buy) at $53.6 per share (Derivative)
      Date: 2026-08-17 | Code: H | Expires: 2035-08-15 | shares_owned_after: 90,441.00 | Footnotes: F6
    • Holds 51,261 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: H | shares_owned_after: 51,261.00 | Footnotes: F7, F8, F8
    • Holds 70,708 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: H | shares_owned_after: 70,708.00 | Footnotes: F7, F9, F9
    • Holds 8,544 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: H | shares_owned_after: 8,544.00 | Footnotes: F7, F10, F10
    • Holds 23,569 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: H | shares_owned_after: 23,569.00 | Footnotes: F7, F11, F11

    Footnotes:

    • F1: Fully exercisable.
    • F2: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
    • F3: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
    • F4: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
    • F5: Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
    • F6: Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
    • F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
    • F8: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
    • F9: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
    • F10: 8,544 restricted stock units vest on 8/15/2027.
    • F11: 11,785 restricted stock units vest on 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
    • F12: 19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029.
    • F13: 93,582 restricted stock units vest on 8/17/2029.

Search

News categories